Endometrial Adenocarcinoma (1)

Endometrial Clear Cell Adenocarcinoma (1)

Endometrial Mucinous Adenocarcinoma (1)

Endometrial Serous Adenocarcinoma (1)

Endometrial Squamous Cell Carcinoma (1)

Endometrial Transitional Cell Carcinoma (1)

Endometrial Undifferentiated Carcinoma (1)

Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm (1)

Recurrent Uterine Corpus Carcinoma (1)

Completed (1)

phase 2 (1)

Gynecologic Oncology Group (1)

National Cancer Institute (NCI) (1)

nintedanib (1)

drug (1)

Other (1)

Interventional (1)

malignant uterine corpus mixed epithelial and mesenchymal neoplasm

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Sep 8, 2017